Dr. Christopher Seet is a hematologist and oncologist subspecializing in the treatment of hematologic malignancies, including hematopoietic stem cell transplantation, cellular therapy, and clinical trials of novel therapeutics. Dr. Seet received his undergraduate degree in Biological Science at the University of Chicago; medical degree at the University of Sydney, Australia; and PhD in Cellular and Molecular Pathology at UCLA. Dr. Seet completed internship and residency in Internal Medicine at Loyola University Medical Center in Chicago, and Hematology/Oncology fellowship at UCLA. Dr. Seet has an active basic science and translational research program in developmental immunology and cellular immunotherapy. His research focuses on human T cell and dendritic cell tumor immunology, and the development of engineered stem cell-based approaches to cancer immunotherapy.
Dr. Seet is a Broad Stem Cell Research Center Clinical Fellow, recipient of a UCLA KL2 Translational Science Award, and a previous UCLA STAR program fellow. He is a member of the American Society of Hematology and American Society of Clinical Oncology.
Artificial organ may help patients form the cancer-fighting cells they need - digitaltrends.com
Artificial thymus developed at UCLA can produce cancer-fighting T cells from blood stem cells
- UCLA Newsroom
Note: News links may expire without notice.